Primus Diagnostics & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.90 Cr
as on 22-06-2024
- Paid Up Capital ₹ 3.72 Cr
as on 22-06-2024
- Company Age 13 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.91 Cr
as on 22-06-2024
- Revenue -16.48%
(FY 2021)
- Profit -202.98%
(FY 2021)
- Ebitda -39.75%
(FY 2021)
- Net Worth -3.43%
(FY 2021)
- Total Assets 5.81%
(FY 2021)
About Primus Diagnostics & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.90 Cr and a paid-up capital of Rs 3.72 Cr.
The company currently has active open charges totaling ₹4.91 Cr.
Amol Nade, Abhishek Yashod, Aniruddha Joshi, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900PN2011PTC140884
- Company No.
140884
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Primus Diagnostics & Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Nade  | Director | 26-Feb-2018 | Current |
| Abhishek Yashod | Director | 13-Sep-2012 | Current |
| Aniruddha Joshi | Director | 26-Sep-2011 | Current |
| Girish Kakde | Director | 26-Sep-2011 | Current |
Financial Performance and Corporate Structure Insights of Primus Diagnostics & Research Centre.
Primus Diagnostics & Research Centre Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.48% decrease. The company also saw a substantial fall in profitability, with a 202.98% decrease in profit. The company's net worth dipped by a decrease of 3.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Primus Diagnostics & Research Centre?
In 2021, Primus Diagnostics & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akshay Anova Medical And Diagnostic Llp
Active
8 years 11 months Aniruddha Joshi and Girish Kakde are mutual person
Anova Diagnostics Private Limited
Active 9 years 4 months Aniruddha Joshi and Girish Kakde are mutual person
Gourishankar Diagnostics & Research Centre Private Limited
Active 13 years 3 months Girish Kakde is a mutual person
Shriram Ct Scan & Diagnostics Private Limited
Active 11 years 1 month Girish Kakde is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jan 2023 | ₹1.80 Cr | Open |
Axis Bank Limited Creation Date: 26 Mar 2022 | ₹9.95 M | Open |
Bank Of Maharashtra Creation Date: 09 Nov 2012 | ₹2.12 Cr | Open |
How Many Employees Work at Primus Diagnostics & Research Centre?
Unlock and access historical data on people associated with Primus Diagnostics & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 31, 2018, Primus Diagnostics & Research Centre has raised a total of ₹ 3.94 Cr, with the most recent deal valued at ₹ 2.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
